-Down to Earth Government sidelines its committee of experts to set up new panel to review India's intellectual property rights policy The politics of protecting intellectual property rights (IPR) is becoming more curiouswith the commerce ministry setting up a think tank to draft a national IPR policy while sidelining a committee of experts it had set up earlier. Annoyed academics who were asked to help formulate the policy in July this year...

-The Indian Express On the 30th anniversary of the Bhopal disaster, memories of the victims' suffering surface once again. One is at a loss for words to describe what happened on the intervening night of December 2-3, 1984. Was it an accident? Or was it industrial genocide? We will never know what it was, since no investigation was conducted on what caused water to leak into 41 tonnes of higly toxic...

-Economic and Political Weekly The National Democratic Alliance government has constituted the IPR Think Tank which, among other things, is to draft the National Intellectual Property Rights Policy. India may not have a policy per se but it has a strong legislation on IPRs, a functioning patents office and mechanisms to grant patents as well as protect consumer interests. The Think Tank has other issues it needs to address, but is...

-The Hindu The Indira Gandhi National Open University (IGNOU) cannot hold the prospects of the country's hearing impaired ransom to the whims of a single individual head of institution. In a patently regressive move, the premier university has recently decided to shut down the Indian Sign Language Research and Training Centre (ISLRTC) from the current academic year. This, despite the growing emphasis on signing as a language to bridge the...

-The Business Standard Angelina Jolie has inadvertently highlighted a key question about patenting Angelina Jolies recent double mastectomy was obviously a very radical decision. It is unusual for a healthy person to opt for pre-emptive surgery to avert the probability, however high it may be, of getting cancer. The tests Jolie relied on are also at the heart of a legal battle, which could affect US biotech patenting norms. Since the US...